.png)
Specialty Active Pharmaceutical Ingredients Market by Product Type and Application- Global Industry Analysis & Forecast to 2027
Published On : November 2020 Pages : 163 Category: Pharmaceuticals Report Code : HC1113515
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Specialty Active Pharmaceutical Ingredients Market By Product Type (Steroidal API, Peptide API, Carbohydrate API, Small Molecule API, High Potency AP) and Application (CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Rheumatology, Diabetes, Oncology, Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Specialty Active Pharmaceutical Ingredients Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Specialty Active Pharmaceutical Ingredients are substance used in a finished pharmaceutical product, intended to furnish pharmacological activity or to otherwise have direct effect in the diagnosis, cure, mitigation, treatment or prevention of disease, or to have direct effect in restoring, correcting or modifying physiological functions in human being.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Specialty Active Pharmaceutical Ingredients Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Sanofi
- Cambrex
- Almac
- Johnson Matthey
- PolyPeptide
- AmbioPharm
- Avecia
- ST Pharm
- Biospring
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Specialty Active Pharmaceutical Ingredients Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o Steroidal API
o Peptide API
o Carbohydrate API
o Small Molecule API
o High Potency AP
· Specialty Active Pharmaceutical Ingredients Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o CNS
o Cardiovascular
o Genitourinary/Hormonal Drugs
o Rheumatology
o Diabetes
o Oncology
o Others
· Specialty Active Pharmaceutical Ingredients Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Sanofi
o Cambrex
o Almac
o Johnson Matthey
o PolyPeptide
o AmbioPharm
o Avecia
o ST Pharm
o Biospring
· Specialty Active Pharmaceutical Ingredients Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Specialty Active Pharmaceutical Ingredients Market, By Country
o U.S. Specialty Active Pharmaceutical Ingredients Market
o Canada Specialty Active Pharmaceutical Ingredients Market
o Mexico Specialty Active Pharmaceutical Ingredients Market
o Europe
§ Europe Specialty Active Pharmaceutical Ingredients Market, By Country
o UK Specialty Active Pharmaceutical Ingredients Market
o Germany Specialty Active Pharmaceutical Ingredients Market
o France Specialty Active Pharmaceutical Ingredients Market
o Russia Specialty Active Pharmaceutical Ingredients Market
o Italy Specialty Active Pharmaceutical Ingredients Market
o Rest of Europe Specialty Active Pharmaceutical Ingredients Market
o Asia-Pacific
§ Asia-Pacific Specialty Active Pharmaceutical Ingredients Market, By Country
o China Specialty Active Pharmaceutical Ingredients Market
o Japan Specialty Active Pharmaceutical Ingredients Market
o South Korea Specialty Active Pharmaceutical Ingredients Market
o India Specialty Active Pharmaceutical Ingredients Market
o Southeast Asia Specialty Active Pharmaceutical Ingredients Market
o Rest of Asia-Pacific Specialty Active Pharmaceutical Ingredients Market
o South America
§ South America Specialty Active Pharmaceutical Ingredients Market
o Brazil Specialty Active Pharmaceutical Ingredients Market
o Argentina Specialty Active Pharmaceutical Ingredients Market
o Columbia Specialty Active Pharmaceutical Ingredients Market
o Rest of South America Specialty Active Pharmaceutical Ingredients Market
o Middle East and Africa
§ Middle East and Africa Specialty Active Pharmaceutical Ingredients Market
o Saudi Arabia Specialty Active Pharmaceutical Ingredients Market
o UAE Specialty Active Pharmaceutical Ingredients Market
o Egypt Specialty Active Pharmaceutical Ingredients Market
o Nigeria Specialty Active Pharmaceutical Ingredients Market
o South Africa Specialty Active Pharmaceutical Ingredients Market
o TurkeySpecialty Active Pharmaceutical Ingredients Market
o Rest of MEA Specialty Active Pharmaceutical Ingredients Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Specialty Active Pharmaceutical Ingredients Market, By Product Type
5.1. Introduction
5.2. Global Specialty Active Pharmaceutical Ingredients Revenue and Market Share by Product Type (2017-2021)
5.2.1. Global Specialty Active Pharmaceutical Ingredients Revenue and Revenue Share by Product Type (2017-2021)
5.3. Steroidal API
5.3.1. Global Steroidal API Revenue and Growth Rate (2017-2021)
5.4. Peptide API
5.4.1. Global Peptide API Revenue and Growth Rate (2017-2021)
5.5. Carbohydrate API
5.5.1. Global Carbohydrate API Revenue and Growth Rate (2017-2021)
5.6. Small Molecule API
5.6.1. Global Small Molecule API Revenue and Growth Rate (2017-2021)
5.7. High Potency AP
5.7.1. Global High Potency AP Revenue and Growth Rate (2017-2021)
6. Specialty Active Pharmaceutical Ingredients Market, By Applications
6.1. Introduction
6.2. Global Specialty Active Pharmaceutical Ingredients Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Specialty Active Pharmaceutical Ingredients Revenue and Revenue Share by Applications (2017-2021)
6.3. CNS
6.3.1. Global CNS Revenue and Growth Rate (2017-2021)
6.4. Cardiovascular
6.4.1. Global Cardiovascular Revenue and Growth Rate (2017-2021)
6.5. Genitourinary/Hormonal Drugs
6.5.1. Global Genitourinary/Hormonal Drugs Revenue and Growth Rate (2017-2021)
6.6. Rheumatology
6.6.1. Global Rheumatology Revenue and Growth Rate (2017-2021)
6.7. Diabetes
6.7.1. Global Diabetes Revenue and Growth Rate (2017-2021)
6.8. Oncology
6.8.1. Global Oncology Revenue and Growth Rate (2017-2021)
6.9. Others
6.9.1. Global Others Revenue and Growth Rate (2017-2021)
7. Specialty Active Pharmaceutical Ingredients Market, By Region
7.1. Introduction
7.2. Global Specialty Active Pharmaceutical Ingredients Revenue and Market Share by Regions
7.2.1. Global Specialty Active Pharmaceutical Ingredients Revenue by Regions (2017-2021)
7.3. North America Specialty Active Pharmaceutical Ingredients by Countries
7.3.1. North America Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2017-2021)
7.3.2. North America Specialty Active Pharmaceutical Ingredients Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Specialty Active Pharmaceutical Ingredients by Countries
7.4.1. Europe Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2017-2021)
7.4.2. Europe Specialty Active Pharmaceutical Ingredients Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Specialty Active Pharmaceutical Ingredients by Countries
7.5.1. Asia-Pacific Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Specialty Active Pharmaceutical Ingredients Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Specialty Active Pharmaceutical Ingredients by Countries
7.6.1. South America Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2017-2021)
7.6.2. South America Specialty Active Pharmaceutical Ingredients Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Specialty Active Pharmaceutical Ingredients by Countries
7.7.1. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Sanofi
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Cambrex
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Almac
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Johnson Matthey
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. PolyPeptide
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. AmbioPharm
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Avecia
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. ST Pharm
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Biospring
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.1. Global Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Specialty Active Pharmaceutical Ingredients Market Forecast by Regions (2022-2027)
9.2.1. North America Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.1.1. United States Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.1.2. Canada Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.1.3. Mexico Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.2. Europe Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.2.1. Germany Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.2.2. France Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.2.3. UK Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.2.4. Russia Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.2.5. Italy Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.3. Asia-Pacific Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.3.1. China Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.3.2. Japan Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.3.3. Korea Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.3.4. India Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.4. South America Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.4.1. Brazil Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.4.2. Argentina Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.4.3. Columbia Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.4.4. Rest of South America Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.5. Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.5.3. Egypt Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.5.4. Nigeria Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.5.5. South Africa Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.5.6. Turkey Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Forecast (2022-2027)
9.3. Specialty Active Pharmaceutical Ingredients Market Forecast by Product Type (2022-2027)
9.3.1. Specialty Active Pharmaceutical Ingredients Forecast by Product Type (2022-2027)
9.3.2. Specialty Active Pharmaceutical Ingredients Market Share Forecast by Product Type (2022-2027)
9.4. Specialty Active Pharmaceutical Ingredients Market Forecast by Applications (2022-2027)
9.4.1. Specialty Active Pharmaceutical Ingredients Forecast by Applications (2022-2027)
9.4.2. Specialty Active Pharmaceutical Ingredients Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Specialty Active Pharmaceutical Ingredients Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Steroidal API Revenue and Growth Rate (2017-2019)
Figure Global Peptide API Revenue and Growth Rate (2017-2019)
Figure Global Carbohydrate API Revenue and Growth Rate (2017-2019)
Figure Global Small Molecule API Revenue and Growth Rate (2017-2019)
Figure Global High Potency AP Revenue and Growth Rate (2017-2019)
Table Global Specialty Active Pharmaceutical Ingredients Revenue and Revenue Share by Applications (2017-2019)
Figure Global CNS Revenue and Growth Rate (2017-2019)
Figure Global Cardiovascular Revenue and Growth Rate (2017-2019)
Figure Global Genitourinary/Hormonal Drugs Revenue and Growth Rate (2017-2019)
Figure Global Rheumatology Revenue and Growth Rate (2017-2019)
Figure Global Diabetes Revenue and Growth Rate (2017-2019)
Figure Global Oncology Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Specialty Active Pharmaceutical Ingredients Revenue by Regions (2017-2019)
Figure North America Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure North America Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2017-2019)
Figure North America Specialty Active Pharmaceutical Ingredients by Countries (2017-2019)
Figure North America Specialty Active Pharmaceutical Ingredients Revenue (Million USD) by Countries (2017-2019)
Figure United States Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure United States Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Canada Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Mexico Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Europe Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2017-2019)
Figure Europe Specialty Active Pharmaceutical Ingredients by Countries (2017-2019)
Figure Europe Specialty Active Pharmaceutical Ingredients Revenue (Million USD) by Countries (2017-2019)
Figure Germany Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Germany Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure France Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure UK Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Russia Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Italy Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Rest of Europe Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Asia-Pacific Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Specialty Active Pharmaceutical Ingredients by Countries (2017-2019)
Figure Asia-Pacific Specialty Active Pharmaceutical Ingredients Revenue (Million USD) by Countries (2017-2019)
Figure China Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure China Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Japan Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Korea Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure India Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Southeast Asia Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure South America Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2017-2019)
Figure South America Specialty Active Pharmaceutical Ingredients by Countries (2017-2019)
Figure South America Specialty Active Pharmaceutical Ingredients Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Brazil Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Argentina Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Columbia Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Rest of South America Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Specialty Active Pharmaceutical Ingredients by Countries (2017-2019)
Figure Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Saudi Arabia Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure United Arab Emirates Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Egypt Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Nigeria Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure South Africa Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Turkey Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Specialty Active Pharmaceutical Ingredients Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2017-2019)
Table Sanofi Specialty Active Pharmaceutical Ingredients Financial Overview
Table Cambrex Specialty Active Pharmaceutical Ingredients Financial Overview
Table Almac Specialty Active Pharmaceutical Ingredients Financial Overview
Table Johnson Matthey Specialty Active Pharmaceutical Ingredients Financial Overview
Table PolyPeptide Specialty Active Pharmaceutical Ingredients Financial Overview
Table AmbioPharm Specialty Active Pharmaceutical Ingredients Financial Overview
Table Avecia Specialty Active Pharmaceutical Ingredients Financial Overview
Table ST Pharm Specialty Active Pharmaceutical Ingredients Financial Overview
Table Biospring Specialty Active Pharmaceutical Ingredients Financial Overview
Figure Global Specialty Active Pharmaceutical Ingredients Revenue (Millions USD) and Growth Rate (2019-2027)
Table Specialty Active Pharmaceutical Ingredients Market Forecast by Regions (2019-2027)
Figure North America Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure United States Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Canada Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Mexico Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Europe Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Germany Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure France Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure UK Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Russia Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Italy Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Rest of Europe Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Asia-Pacific Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure China Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Japan Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Korea Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure India Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Southeast Asia Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure South America Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Brazil Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Argentina Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Columbia Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Rest of South America Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Saudi Arabia Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure United Arab Emirates Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Egypt Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Nigeria Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure South Africa Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Turkey Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Forecast (2019-2027)
Figure Global Specialty Active Pharmaceutical Ingredients Forecast by Product Type (2019-2027)
Figure Global Specialty Active Pharmaceutical Ingredients Market Share Forecast by Product Type (2019-2027)
Figure Global Specialty Active Pharmaceutical Ingredients Forecast by Product Type (2019-2027)
Figure Global Specialty Active Pharmaceutical Ingredients Forecast by Applications (2019-2027)
Figure Global Specialty Active Pharmaceutical Ingredients Market Share Forecast by Applications (2019-2027)
Figure Global Specialty Active Pharmaceutical Ingredients Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|